Last reviewed · How we verify

NCT03199456

A Randomized Post-market Study to Evaluate Zip Device Compared to Sutures for Laceration Repair in Pediatrics and Adults

Completed NA Last updated 24 September 2018
What this trial tests

NA trial testing Zip surgical skin closure device in Laceration in 26 participants. Completed in 24 August 2018.

Timeline
16 June 2017
Primary endpoint
25 July 2018
24 August 2018

Quick facts

Lead sponsorZipLine Medical Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment26
Start date16 June 2017
Primary completion25 July 2018
Estimated completion24 August 2018
Sites2 locations across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

ZipLine Medical Inc.

Who can join

4 and older, any sex, with Laceration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Zip-009 clinical investigation will enroll 26 paediatric and adult subjects requiring laceration repair and fulfilling the eligibility criteria for the clinical investigation. The investigation is designed to evaluate the time and cost savings and the satisfaction and outcomes of the Zip device compared to conventional sutures. The subjects will be randomly assigned at a 1:1 ratio to either the Zip Surgical Skin Closure Device group or the Standard of Care sutures group. The investigation consists of one screening/baseline visits at day 0 where the subject will be treated with either the Zip device or sutures, and thereafter two follow up telephone calls at day 10 and day 30. The Zip device/sutures will be removed prior the first follow up call day 10. The duration of the investigation is estimated to 5 months, including a 4-month recruitment period and 1-month follow up period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other ZipLine Medical Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03199456.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing